跳至主要内容
临床试验/NCT01550393
NCT01550393已完成不适用

Discovery and Validation of Wilms Tumor Markers Using Urine Proteomics

Children's Oncology Group0 个研究点目标入组 100 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
主要终点
Wilms tumor biomarkers identified by ELISA

研究概览

简要总结

RATIONALE: Studying samples of urine from patients with cancer in the laboratory may help doctors identify biomarkers related to cancer.

PURPOSE: This clinical trial studies biomarkers in urine from patients with Wilms tumor.

详细描述

OBJECTIVES:

  • To validate the prognostic performance of specific-candidate Wilms tumor markers by measuring their urinary concentration using enzyme-linked immunosorbent assays (ELISAs) in urine specimens collected at diagnosis from 50 patients with favorable histology Wilms tumor who relapsed and 50 patients who did not relapse.

OUTLINE: Urine specimens are analyzed using enzyme-linked immunosorbent assays (ELISAs) for biomarkers.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
— 至 120 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Wilms tumor biomarkers identified by ELISA

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

相似试验